(18928389), M. C. J., (22676472), G. A. R., (6887384), J. M. S., (783181), N. C., (22676475), M. C. T., & (22676478), L. M. N. (2025). Spearman correlation coefficient (r<sub>s</sub>) between echocardiographic measurements (i.e., left atrial: Aortic root diameter; LA:Ao), markers of loss of GI barrier function (i.e., lipopolysaccharide; LPS), and cardiac (i.e., troponin) and systemic (i.e., cytokines) inflammation in 36 dogs with untreated myxomatous mitral valve disease (MMVD).
Dyfyniad Arddull Chicago(18928389), Maria C. Jugan, Gabrielle A. Rands (22676472), Joerg M. Steiner (6887384), Natalia Cernicchiaro (783181), Matthew C. Tanner (22676475), and Lillian M. Novotny (22676478). Spearman Correlation Coefficient (r<sub>s</sub>) Between Echocardiographic Measurements (i.e., Left Atrial: Aortic Root Diameter; LA:Ao), Markers of Loss of GI Barrier Function (i.e., Lipopolysaccharide; LPS), and Cardiac (i.e., Troponin) and Systemic (i.e., Cytokines) Inflammation in 36 Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD). 2025.
Dyfyniad MLA(18928389), Maria C. Jugan, et al. Spearman Correlation Coefficient (r<sub>s</sub>) Between Echocardiographic Measurements (i.e., Left Atrial: Aortic Root Diameter; LA:Ao), Markers of Loss of GI Barrier Function (i.e., Lipopolysaccharide; LPS), and Cardiac (i.e., Troponin) and Systemic (i.e., Cytokines) Inflammation in 36 Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD). 2025.